Alembic Mami

Alembic Mami is a pharmaceutical joint venture based in Algeria, established in 2014 through a partnership between India's Alembic Pharmaceuticals and the local firm Adwiya Mami. The company operates a large-scale formulation plant in Constantine, Algeria, which has an annual production capacity of approximately 1.2 billion oral solid dosage units. This facility serves as a strategic hub for Alembic's expansion into the Algerian and broader African markets, focusing on the production of high-quality generic medicines. The company's portfolio primarily includes treatments for cardiovascular conditions and anti-infectives, all manufactured in adherence to international cGMP standards. By establishing a local manufacturing presence, Alembic Mami effectively navigates Algeria's regulatory landscape and trade barriers to provide affordable healthcare solutions to the region.